000764219 000__ 01716cam\a2200433Mi\4500
000764219 001__ 764219
000764219 005__ 20230306142405.0
000764219 006__ m\\\\\o\\d\\\\\\\\
000764219 007__ cr\un\nnnunnun
000764219 008__ 161111s2016\\\\sz\\\\\\o\\\\\000\0\eng\d
000764219 019__ $$a962303144$$a962814331$$a965343988
000764219 020__ $$a9783319460918$$q(electronic book)
000764219 020__ $$a3319460919$$q(electronic book)
000764219 020__ $$z9783319460901
000764219 020__ $$z3319460900
000764219 035__ $$aSP(OCoLC)ocn962436458
000764219 035__ $$aSP(OCoLC)962436458$$z(OCoLC)962303144$$z(OCoLC)962814331$$z(OCoLC)965343988
000764219 040__ $$aYDX$$beng$$epn$$cYDX$$dN$T$$dGW5XE$$dIDEBK$$dN$T$$dEBLCP$$dOCLCQ$$dOCLCF
000764219 049__ $$aISEA
000764219 050_4 $$aRC271.P76
000764219 08204 $$a615.7/98$$223
000764219 24500 $$aResistance to tyrosine kinase inhibitors /$$cDaniele Focosi, editor.
000764219 260__ $$aCham, Switzerland :$$bSpringer,$$c©2016.
000764219 300__ $$a1 online resource.
000764219 336__ $$atext$$btxt$$2rdacontent
000764219 337__ $$acomputer$$bc$$2rdamedia
000764219 338__ $$aonline resource$$bcr$$2rdacarrier
000764219 4901_ $$aResistance to targeted anti-cancer therapeutics ;$$vvolume 10
000764219 506__ $$aAccess limited to authorized users.
000764219 588__ $$aDescription based on print version record.
000764219 650_0 $$aProtein-tyrosine kinase$$xInhibitors.
000764219 650_0 $$aDrug resistance.
000764219 7001_ $$aFocosi, Daniele,$$eeditor.
000764219 77608 $$iPrint version:$$tResistance to tyrosine kinase inhibitors.$$dCham, Switzerland : Springer, ©2016$$z3319460900$$z9783319460901$$w(OCoLC)956480190
000764219 830_0 $$aResistance to targeted anti-cancer therapeutics ;$$vv. 10.
000764219 852__ $$bebk
000764219 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-46091-8$$zOnline Access$$91397441.1
000764219 909CO $$ooai:library.usi.edu:764219$$pGLOBAL_SET
000764219 980__ $$aEBOOK
000764219 980__ $$aBIB
000764219 982__ $$aEbook
000764219 983__ $$aOnline
000764219 994__ $$a92$$bISE